Age-Related Macular Degeneration (AMD)

Similar documents
Information for patients

Treatment of Age Related Macular Degeneration (AMD) by Intravitreal Injection

RETINAL CONDITIONS RETINAL CONDITIONS

Age-Related. macular degeneration.

Introduction How the eye works

INFORMED CONSENT FOR AVASTIN TM (BEVACIZUMAB) INTRAVITREAL INJECTION

GENERAL INFORMATION DIABETIC EYE DISEASE

Intravitreal Injection

Brampton Hurontario Street Brampton, ON L6Y 0P6

A Patient s Guide to Diabetic Retinopathy

What is Age-Related Macular Degeneration?

The Human Eye. Cornea Iris. Pupil. Lens. Retina

Diabetes & Your Eyes


Photodynamic Therapy (PDT) for agerelated

Diabetic Retinopathy A Presentation for the Public

Photodynamic therapy (PDT) for Central Serous Retinopathy (CSR)/ Polypoidal Choroidal Vasculopathy (PCV)

Treatment of wet macular degeneration by intravitreal injection with Ranibizumab (Lucentis) or Aflibercept (Eylea): Information and consent

Facts About Diabetic Eye Disease

Diabetic retinopathy damage to the blood vessels in the retina. Cataract clouding of the eye s lens. Cataracts develop at an earlier age in people

Flashers and Floaters

If you would like further information, please ask any of the staff at the clinic. They will be happy to help.

Understanding Diabetic Retinopathy

The Foundation WHAT IS THE RETINA?

Treatment of Retinal Vein Occlusion (RVO)

Diabetic Retinopathy WHAT IS DIABETIC RETINOPATHY? WHAT CAUSES DIABETIC RETINOPATHY? WHAT ARE THE STAGES OF DIABETIC RETINOPATHY?

Patient Information: Macular Hole Surgery

Ophthamology Directorate. Eye Injection for Macular Disorders Information for Patients

ILUVIEN 190 micrograms intravitreal implant in applicator (fluocinolone acetonide)

Retinal Tear and Detachment

Scrub In. What is the function of vitreous humor? What does the pupil do when exposed to bright light? a. Maintain eye shape and provide color vision

Fluorescein and Indocyanine Green Angiography Guidelines

OAKLEIGH EYE CENTRE. THE EYE Before looking at diabetic retinopathy it is important to understand what the healthy eye looks like and how it works.

Age-related Macular Degeneration (AMD) treatment information

Clinically Significant Macular Edema (CSME)

Cataract. What is a Cataract?

Age-Related Macular Degeneration

Cataract. What is a Cataract?

Treatment of Diabetic Macular Oedema by Intravitreal Injection with Ranibizumab (Lucentis)

Diabetic Retinopathy Information

Patient Information Cataract Surgery

Cataract Surgery: Information for patients. Back of eye. Vitreous. Retina. Lens

What You Should Know About Angioid Streaks By David J. Browning, MD, PhD

Information for Patients undergoing Intravitreal Triamcinolone Acetonide (Kenalog) Injection

Caregiver s guide to wet AMD

Dr Dianne Sharp Ophthalmologist Retina Specialists, Parnell Greenlane Clinical Centre

Macular Hole. Helpline

Screening saves sight. The importance of regular testing for diabetic retinopathy

Vision loss in elderly. Erica Weir, April 2015

Vision loss in elderly

Intravitreal Injections for Wet Age Related Macular Degeneration

Diabetic Eye Disease

Retinal Tears and Detachments

The Foundation. continued next page. RETINA HEALTH SERIES Facts from the ASRS

Information for patients considering cataract surgery Castleton Day Surgery Unit, Yeatman Hospital, Sherborne

Patient information Eylea treatment for diabetic macular oedema (DMO)

Ophthalmology. Ophthalmology Services

Vitrectomy for diabetic vitreous haemorrhage

EYLEA. (aflibercept solution for injection) Patient Guide

Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR)

MANAGING DIABETIC RETINOPATHY. <Your Hospital Name> <Your Logo>

DIABETIC RETINOPATHY

Age-Related Eye Diseases and Conditions. Jonathan M. Frantz, MD, F.A.C.S. Cataract and Refractive Surgeon

Diabetic Retinopathy What You Should Know. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute

Here s what you need to know about your treatment with JETREA (ocriplasmin)

Diabetic Retinopathy

VISIONCARE S IMPLANTABLE MINIATURE TELESCOPE (by Dr. Isaac Lipshitz)

Diabetes and Eye Health more than meets the eye Vision Initiative - in association with PSA

Eye injection treatment costs and rebates

DIABETIC RETINOPATHY

Cataract Surgery. Patient Information. How your care will be organised. Introduction

Eye injection treatment costs and rebates

How the eye works. Causes of retinitis pigmentosa

GHPI0100_06_10 Contact: Ophthalmology Review due: June What is a Cataract?

UVEITIS IN GENERAL. Information for patients UVEITIS CLINIC WHAT IS UVEITIS? MAIN CATEGORIES OF UVEITIS

Preparing for laser treatment for diabetic retinopathy and maculopathy

X-Plain Diabetic Retinopathy Reference Summary

Asymptomatic retinal detachment

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone

The Foundation WHAT IS THE RETINA? continued next page. RETINA HEALTH SERIES Facts from the ASRS

PATIENT INFORMATION LEAFLET MACULAR HOLE. What is the macula?

Diabetic Retinopathy

Chapter 32. Hearing, Speech, and Vision Problems. Copyright 2019 by Elsevier, Inc. All rights reserved.

Important: Please read before your appointment

PATIENT STUDY INFORMATION LEAFLET

Cataracts are a normal feature of aging. About half of adults aged 65 to 74 have cataracts.

In all cases, a doctor will explain the procedure to you and answer any questions you may have.

Macular holes. What is a macular hole?

LEARN HOW TO PROTECT YOUR EYES FROM DIABETIC VISION LOSS

Age-related macular degeneration (AMD) and RANIBIZUMAB (Lucentis)

Diagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City

When Eyes Show Their Age

Uveitis / Iritis. Introduction. Other formats

OPTIHEAL NEW VISION NEW LIFE. Toll-free line :

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM OZURDEX, dexamethasone 700 μg intravitreal implant

What is Fundus Fluorescein Angiography and Indocyanine Green Angiography?

Information for Patients. Retinal Detachment

Ruthenium plaque treatment

UNDERSTANDING COMMON EYE DISEASES INTRODUCTION. Diseases of the eye are very common and if a Certified Nursing Assistant

Mild NPDR. Moderate NPDR. Severe NPDR

Transcription:

Age-Related Macular Degeneration (AMD) What is the Macula? What is Dry AMD (Age-related Macular Degeneration)? Dry AMD is an aging process that causes accumulation of waste product under the macula leading to the formation of drusen. Drusen are yellow spots or deposits under the macula which gradually enlarge with time. Large drusen can damage the light receptor cells of the macula leading to gradual worsening of central vision. Dry AMD - Yellow deposits at the Macula called Drusen How does Dry AMD affect my vision? Patients will gradually notice difficulty with detailed visual tasks such as reading. They may notice distortion - which is straight lines or edges appearing wavy. This can be checked with an Amsler grid. As the condition deteriorates, patches of missing vision or "blind spots" start to appear in the central vision which can enlarge with time. AMD usually does not affect the peripheral vision unless the patient has another eye condition (eg Glaucoma).

Distortion of central vision detected on an Amsler grid What can we do to prevent Dry AMD? Although some of us are more likely to develop AMD than others because of our genetic make-up, there are a few things we can do to reduce our risk of AMD Stop smoking - This is beneficial even if the patient has a long history of heavy smoking. Besides, stopping smoking has benefits for other parts of the body as well. Control your Blood Pressure - Hypertension is a risk factor for AMD as well as Cardiovascular diseases such as stroke and heart attack. Diet - Have lots of green leafy vegetables and fish in your diet. Vitamin and Zinc supplements - AREDS 1 was a landmark study that showed that when patients reach a certain stage of dry AMD, these supplements can help to slow down the degeneration and loss of vision.. Speak to your ophthalmologist about which supplements may be beneficial for you. Amsler Grid - If you have AMD, daily monitoring of your vision with the grid will allow you to detect sudden worsening in vision if Dry AMD progresses to Wet AMD What should I do if I have a family history of AMD? If you are over 50 years of age and have a first-degree relative with AMD then it would be useful to have your macula checked. This is especially so if there has been a change in your vision. The genetics of AMD is an area of active research as more AMD genes are being identified. What is Wet AMD? Wet AMD occurs in 10 percent of Dry AMD patients. The damage to the deep layers of the macula by drusen can allow an abnormal blood vessel to grow under the macula. This blood vessel can enlarge, bleed and leak fluid into the macula resulting in rapid loss of central vision. Wet AMD causes a sudden increase in distortion or a dark shadow appearing in the middle of the vision, more noticeable when vision is checked on the Amsler Grid.

Wet AMD - Sudden Bleeding at the Macula What will your Ophthalmologist do if Wet AMD is suspected? After a thorough clinical assessment, including a dilated examination of the macula, your ophthalmologist may arrange further testing for you. One test is an OCT (Ocular Coherence Tomography) scan of the macula. The scan is safe, painless, quick and provides the ophthalmologist with a high resolution image of the macula. Repeat OCT scans are often used to monitor progress of treatment. Normal OCT scan of the Macula OCT scan of Wet AMD showing leakage and swelling The other test your Ophthalmologist may require to manage your AMD is a Fluorescein Angiogram. What is a Fluorescein Angiogram? Fluorescein angiography is a photographic test of the retina. A yellow dye called fluorescein is injected into a vein in your arm, where it travels through the body reaching the eye. A special camera uses bright flashes of light to take multiple photographs of the back of your eye as the dye passes through the blood vessels of the retina. In Wet AMD the dye will leak out of the abnormal blood vessel and it will show up as a bright spot on the photos. This angiogram not only makes the diagnosis but it will tell us the size of the blood vessel and its location. This information will be used to determine the best treatment option.

Patient having a Fluorescein Angiogram What are the side effects of Fluorescein Angiography? After fluorescein angiography, your skin will turn yellow for several hours. This will fade as the dye is filtered out by the kidneys causing the urine to turn bright yellow for up to 24 hours. Your vision will be blurred and you should not drive for the remainder of the day. There is no permanent effect on the vision from the test. The chance of an adverse effect is low, but as with any medical procedure there are some risks involved. Some patients experience nausea during the angiogram.. Some patients may vomit. Occasionally some fluorescein will leak from a fragile vein, which may cause a burning sensation and yellow staining of skin. The burning usually lasts a few minutes and the staining takes a few days to disappear. Some patients may experience an allergic reaction to the fluorescein dye. The most frequent allergic reaction is a skin rash, which is often itchy and may appear within minutes after the fluorescein injection. The most severe allergic reaction is called anaphylaxis, which is rare but may be life threatening. Very rarely patients may experience breathing difficulty or heart rhythm disturbances, which can be severe and even cause death. If you feel any itching, tingling in the lips or tongue, difficulty breathing or pain during or after the angiogram, let us know immediately. You may require medication to control the reaction, and your condition will be monitored until it has been resolved. Delayed reactions are rare. How is Wet AMD treated? Focal Laser If the blood vessel is small and located away from the centre of the macula, then it is possible to apply laser to seal off the blood vessel. However, there is a 50 percent chance that the blood vessel could grow back again.

PDT (Photodynamic Therapy) Laser If the blood vessel is under the centre of the macula, focal laser cannot be used as it would result in an immediate central blind spot with a significant drop in vision. PDT laser was widely used for this situation in the past. It involves infusing a photosensitive medication called Verteporfin into a vein on the arm. This medication accumulates in the abnormal blood vessel at the macula. "Cold" laser is then applied to the blood vessel to "activate" the medication within it. This has the effect of sealing off the blood vessel. PDT laser needs to be repeated every 2 to 3 months until the blood vessel is completely sealed. Unfortunately, very few patients had improvement in vision and a significant proportion still lost vision from the disease. This led to the development of Lucentis injections which has become the standard of care for Wet AMD. Lucentis Injections Lucentis or Ranibizumab was listed on the PBS in 2007 and has now become the treatment of choice for Wet AMD in Australia and in many parts of the Western world. Lucentis is injected into the eye and has the effect of stopping the growth of the abnormal blood vessel as well as reducing the amount of fluid leakage from it. Results from large, international studies of this medication show that 70 percent of patients maintain or have improved vision. Some may lose a small amount of vision. Only a small percentage do not respond to treatment. Avastin Injections Avastin or Bevacizumab is licensed as an intravenous treatment for bowel cancer. However, due to its molecular similarity to Lucentis, it has been found to be just as effective in the treatment of Wet AMD. In this off-label use of Avastin, the drug is divided into small doses by a compounding pharmacy and then injected into the eye using the same technique as Lucentis injections. In certain cases of Wet AMD where Lucentis is not Medicare approved, Avastin can be considered. How are Eye (Intravitreal) Injections given? Firstly, anaesthetic eye drops are used. Then further anaesthetic can be delivered by an injection under the conjunctiva (the surface layer of the white of the eye). The eye is then washed with Betadine antiseptic to minimise the risk of infection. A fine 30-gauge needle is then inserted gently through the white part of the eye to deliver 0.05ml of either Lucentis or Avastin. The medication will then spread to the macula to "shut down" the abnormal blood vessel. In most cases an eye pad will be placed over the injected eye and a short course of eye antibiotics given. What are the risks of eye injections? The eye could be gritty and occasionally painful for the first 24 to 48 hours due to the drying effects of Betadine. This usually settles down with ocular lubricants, ointments and simple pain-killers (eg Paracetamol). Often, tiny air bubbles are injected into the eye which appear as round floaters or dark spots in the vision. Again, this is harmless and should disappear over the next few days.

Serious sight-threatening complications are fortunately rare and they include infection (endophthalmitis), bleeding and retinal detachment. The risk of infection, for example is 1 in 2000. Injury to the lens can result in cataract. Emergency eye surgery may be needed to the save the sight in this situation. How frequent and how long is the course of injections? Lucentis and Avastin in the eye wears off 4 weeks after the injection. Therefore, in the initial phase, the injections needs to be given every 4 weeks. When the blood vessel appears to be under control, treatments can be extended. Although there are obvious benefits in spreading out the injections, there is also the risk that the blood vessel may reactivate, leading to further leakage and bleeding which can in turn affect the vision permanently. Treatment has to be individualised for each patient. Currently, the evidence supports ongoing treatments indefinitely. The patient can decide to stop treatment for various reasons but there is a risk that the vision could worsen if the blood vessel reactivates sometime in the future. It is important to discuss any decision to stop treatment with your Ophthalmologist first. What is the risk of Wet AMD in the good eye? There is a 50 percent chance that the "good" eye will develop Wet AMD. Therefore it is essential that the patient monitors the vision in the good eye with the Amsler grid and report any new or increasing distorsion promptly to the Ophthalmologist. Vitamin and Zinc supplementation works best in this situation to reduce the risk of Wet AMD in the good eye. Speak to your ophthalmologist about this.